Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immune response
|
| gptkbp:administeredBy |
pregnant women
Rh-negative individuals |
| gptkbp:alsoKnownAs |
gptkb:Rho(D)_immune_globulin
|
| gptkbp:approvedBy |
gptkb:FDA
1968 |
| gptkbp:ATCCode |
gptkb:J06BB01
|
| gptkbp:CASNumber |
80723-08-6
|
| gptkbp:category |
gptkb:monoclonal_antibody
immunotherapy blood product |
| gptkbp:contraindication |
hypersensitivity to immunoglobulins
|
| gptkbp:discoveredIn |
1960s
|
| gptkbp:essentialMedicine |
true
|
| https://www.w3.org/2000/01/rdf-schema#label |
Anti-D immunoglobulin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:BayRho-D
gptkb:WinRho RhoGAM HyperRHO Rhophylac |
| gptkbp:mechanismOfAction |
binds to RhD antigen on red blood cells
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prevention |
hemolytic disease of the newborn
sensitization to RhD antigen |
| gptkbp:producedBy |
human plasma
|
| gptkbp:PubChem_CID |
25077121
|
| gptkbp:routeOfAdministration |
intramuscular injection
intravenous injection |
| gptkbp:sideEffect |
fever
headache allergic reactions injection site reactions |
| gptkbp:UNII |
QX9KQ3FJ1L
|
| gptkbp:usedFor |
miscarriage
abortion childbirth amniocentesis treatment of immune thrombocytopenic purpura prevention of Rh disease abdominal trauma during pregnancy |
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:Rho(D)_immune_globulin
|
| gptkbp:bfsLayer |
8
|